Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Yau T, Park JW, Finn RS, Cheng AL, Mathurin P, Edeline J, Kudo M, Harding JJ, Merle P, Rosmorduc O, Wyrwicz L, Schott E, Choo SP, Kelley RK, Sieghart W, Assenat E, Zaucha R, Furuse J, Abou-Alfa GK, El-Khoueiry AB, Melero I, Begic D, Chen G, Neely J, Wisniewski T, Tschaika M, Sangro B. Yau T, et al. Among authors: melero i. Lancet Oncol. 2022 Jan;23(1):77-90. doi: 10.1016/S1470-2045(21)00604-5. Epub 2021 Dec 13. Lancet Oncol. 2022. PMID: 34914889 Clinical Trial.
Gene therapy of primary and metastatic liver tumors.
Prieto J, Qian C, Melero I, Sangro B, Mazzolini G, Narvaiza I, Barajas M. Prieto J, et al. Among authors: melero i. Med Sci Monit. 2001 May;7 Suppl 1:76-7. Med Sci Monit. 2001. PMID: 12211755 Free article. No abstract available.
The promise of gene therapy in gastrointestinal and liver diseases.
Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J. Prieto J, et al. Among authors: melero i. Gut. 2003 May;52 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/gut.52.suppl_2.ii49. Gut. 2003. PMID: 12651882 Free PMC article. Review.
Biologic therapy of liver tumors.
Prieto J, Qian C, Sangro B, Melero I, Mazzolini G. Prieto J, et al. Among authors: melero i. Surg Clin North Am. 2004 Apr;84(2):673-96. doi: 10.1016/S0039-6109(03)00230-5. Surg Clin North Am. 2004. PMID: 15062668 Free article. Review.
Gene therapy of cancer based on interleukin 12.
Sangro B, Melero I, Qian C, Prieto J. Sangro B, et al. Among authors: melero i. Curr Gene Ther. 2005 Dec;5(6):573-81. doi: 10.2174/156652305774964712. Curr Gene Ther. 2005. PMID: 16457647 Review.
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.
Alfaro C, Perez-Gracia JL, Suarez N, Rodriguez J, Fernandez de Sanmamed M, Sangro B, Martin-Algarra S, Calvo A, Redrado M, Agliano A, Gonzalez A, Rodriguez I, Bolaños E, Hervás-Stubbs S, Perez-Calvo J, Benito A, Peñuelas I, Vigil C, Richter J, Martinez-Forero I, Melero I. Alfaro C, et al. Among authors: melero i. J Immunol. 2011 Dec 1;187(11):6130-42. doi: 10.4049/jimmunol.1102209. Epub 2011 Nov 2. J Immunol. 2011. PMID: 22048768 Free article. Clinical Trial.
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, Lasarte JJ, Pérez-Gracia JL, Melero I, Prieto J. Sangro B, et al. Among authors: melero i. J Hepatol. 2013 Jul;59(1):81-8. doi: 10.1016/j.jhep.2013.02.022. Epub 2013 Mar 4. J Hepatol. 2013. PMID: 23466307 Clinical Trial.
356 results